Aurinia Pharmaceuticals Inc. (AUPH) estimates and forecasts 4 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00, with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00. H.C. Wainwright have made an estimate for Aurinia Pharmaceuticals Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 25, 2021. A Backdoor Way To Profit From Today’s Crypto Bull Market. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Price … $14.12 is my target over the next few trading days. A number of other research firms have also recently commented on AUPH. The Goodyear Tire & Rubber Company (NASDAQ: GT) has acquired rival Cooper Tire & Rubber Company (NYSE: CTB) for $2.8 billion. Save my name, email, and website in this browser for the next time I comment. The average price target is $29.00 with a high forecast of $35.00 and a low forecast of $23.00. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -83.30%. Return on Total Capital for AUPH is now -39.80, given the latest momentum, and Return on Invested Capital for the company is -64.64. View detailed financial information, real-time news, videos, quotes and analysis on Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). An RSI rate of 50 would represent a neutral market momentum. Aurinia Pharm Target Price Projection Aurinia Pharm's current and average target prices are 15.65 and 29.75, respectively. AUPH has a greater average analyst price target than 31.97% of stocks in the mid market cap category. – LUPKYNIS is the first FDA-approved oral therapy for lupus nephritis (LN), a condition that causes irreversible kidney damage and increases the risk of kidney failure, cardiac events, and death -. It’s free. View Price Target Upside (Daily) for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). To see all exchange delays and terms of use, please see disclaimer. Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. Their average twelve-month price target is $27.71, suggesting a possible upside of 98.0%. . This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. With the latest financial reports released by the company, Aurinia Pharmaceuticals Inc. posted -0.22/share EPS, while the average EPS was predicted by analysts to be reported at -0.12/share. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. – LUPKYNIS demonstrated significantly improved renal response rates compared to typical standard-of-care (SoC) in clinical trials. Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Operating Margin for any stock indicates how profitable investing would be, and Aurinia Pharmaceuticals Inc. [AUPH] shares currently have an operating margin of -23977.99. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.70. Over the past six months meanwhile, it has gained 34.55% and gained 35.43% year-on date. Based on 7 analysts offering 12 month price targets for Intra-Cellular Therapies in the last 3 months. • Blink vs. ChargePoint: Which Electric Vehicle Infrastructure Stock is a Better Buy? RedStickBR: Why not sell $18 calls against your underlying right now? All rights reserved. AUPH Stock Summary. Explore commentary … Their average twelve-month price target is $27.71, predicting that the stock has a possible upside of 92.73%. What next? Copyright © 2021. The projected low price target is $17.9 while the price target rests at a high of $35. Join now to get the Newsheater.com pre-market morning brief 100% free. The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. AbCellera price target raised to $52 from $45 at SVB Leerink. That way, if it goes to $18 or above, you get your price target and some additional premium, but if it goes back down, you at least collect some premium. Additionally, 43 investors decreased positions by around 13,722,829 shares, while 16 investors held positions by with 31,443,373 shares. Since FDA approval, six analyst firms including RBC Capital and Oppenheimer have reiterated Buy ratings on AUPH. View Price Target for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. There are presently around $1,219 million, or 55.87% of AUPH stock, in the hands of institutional investors. Based on... Peloton Interactive (PTON) announced plans to enter the Asia Pacific region by launching in Australia. Target Price: 11.50: Perf Year-24.56%: Cash/sh-P/C-EPS next 5Y-ROE-52W Range: 9.83 - 20.50: Perf YTD-8.03%: Dividend-P/FCF-EPS past 5Y-ROI-52W High-37.95%: Beta-Dividend %-Quick Ratio-Sales past 5Y-Gross Margin-52W Low: 29.40%: ATR: 0.86: Employees: 294: Current Ratio-Sales Q/Q: 172417.20%: Oper. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $34 to $28. 8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. Click here now. Vaxart Inc. [VXRT] Is Currently 40.76 above its 200 Period Moving Avg: What Dose This Mean? above. According to . Join. All 'A' Rated Buy Stocks, • 3 Small-Cap Value Stocks for an Improving Economy. Aurinia Pharmaceuticals Inc.’s Net Margin is presently recorded at -38945.28. Positions in Aurinia Pharmaceuticals Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 101 institutional holders increased their position in Aurinia Pharmaceuticals Inc. [NASDAQ:AUPH] by around 19,942,818 shares. Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights Read Press Release View All News The Price to Book ratio for the last quarter was 5.94. BTIG Research has the lowest price target set, forecasting a price of … The... ZW Data Action Technologies Inc. traded at a high on 03/09/21, posting a 21.43 gain after which it closed the day’ session at... Sunworks Inc. jumped around 2.36 points on Tuesday, while shares priced at $13.29 at the close of the session, up 21.59%. Is AUPH a Buy (Price Target) by Finance BroGet a FREE Stock Valued up to $500 with Robinhood - https://join.robinhood.com/zacharf1031Love our content? The present Moving Average for the last 50 days of trading for this stock 14.14, while it was recorded at 15.40 for the last single week of trading, and 14.97 for the last 200 days. The firm has a 50 day moving average price of $14.07 and a 200-day moving average price of $14.42. Aurinia Pharmaceuticals Inc. [NASDAQ: AUPH] surged by $3.87 during the normal trading session on Monday and reaching a high of $20.50 during the day while it closed the day at $18.73. Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by SVB Leerink on 2021-01-27. Aurinia Pharmaceuticals currently has a consensus rating of “Buy” and an average target price of $26.50. The high price target for AUPH is $35.00 and the low price target for AUPH is … DBTNEWS® is a registered trademark. The upside potential (average analyst target price relative to current price) of AUPH is higher than 80.67% of all US stocks. Three of those contained upward price target revisions. Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. HC Wainwright’s target price indicates a potential upside of 98.64% from the company’s current price. Im looking for a bounce up the fibonacci scale . ... Related Articles (AUPH) Earnings Preview: Aurinia … OCUL has experienced a 248.76% gain in the last year, while its stock has... Peloton Interactive (PTON) Is Going To Start Selling Exercise Bikes In Australia. Is AUPH a Buy, Hold or Sell? With this latest performance, AUPH shares gained by 38.64% in over the last four-week period, additionally plugging by 34.55% over the last 6 months – not to mention a drop of -1.16% in the past year of trading. The Average True Range (ATR) for Aurinia Pharmaceuticals Inc. is set at 1.20, with the Price to Sales ratio for AUPH stock in the period of the last 12 months amounting to 20211.11. Ratings...FREE! We do not sell or share your information with anyone. Reflecting on the efficiency of the workforce at the company, Aurinia Pharmaceuticals Inc. [AUPH] managed to generate an average of -$2,650,499 per employee. The current RSI for AUPH stock in for the last two-week period is set at 74.35, with the RSI for the last a single of trading hit 80.13, and the three-weeks RSI is set at 69.73 for Aurinia Pharmaceuticals Inc. [AUPH]. Cantor Fitzgerald decreased their price target on Aurinia Pharmaceuticals from $30.00 to … With a 5-year investment, the revenue is expected to be around +205.36%. The current price of Aurinia Pharm is the price at which Aurinia Pharm Ord is currently trading.
Radio Devon News, Cbeebies Proms Presenters, Nashville Predators Lines 2021, Barnsley - Tranmere H2h, Hampton Inn Franklin, Tn Address, Doctor Who 9/11 Fanfiction,